Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vext Science ( (TSE:VEXT) ) just unveiled an announcement.
Vext Science, Inc. has announced the sale of its medical cannabis processing license in Kentucky for $880,000, as part of a strategic move to concentrate on its core markets in Arizona and Ohio. The transaction is expected to bolster Vext’s balance sheet, aiding in the expansion of its retail operations in Ohio and supporting general corporate purposes. This decision reflects Vext’s disciplined capital allocation strategy and commitment to maximizing returns in its primary operational areas.
More about Vext Science
Vext Science, Inc. is a U.S.-based cannabis operator with vertically integrated operations in Arizona and Ohio. The company specializes in cultivation, manufacturing, and retail operations, producing THC concentrates, edibles, and distillate cartridges under the Vapen brand. Vext focuses on expanding its presence in its core markets of Arizona and Ohio, leveraging cutting-edge science and marketing to enhance customer experience and shareholder value.
YTD Price Performance: 11.54%
Average Trading Volume: 29,503
Technical Sentiment Signal: Strong Buy
Current Market Cap: $35.19M
See more insights into VEXT stock on TipRanks’ Stock Analysis page.